Recent Advancements in Gremlin-1: Breast cancer

Nimrah Inam, Ayesha Hameed, Lubna Vohra, Sana Zeeshan

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

One of the bone's morphogenic protein (BMP) antagonists, Gremlin-1 or GREM-1, can bind directly to BMPs. GREM-1 can act in either BMP-dependent or - independent pathways, according to research. It reinforces organogenesis, tissue differentiation, and organ fibrosis. Recent research from numerous studies has demonstrated the significance of GREM-1 in the initiation, progression, and even metastasis of different cancers, including breast, cervical, gastric, and colorectal cancers. This review highlights the function of GREM-1 in the development of breast cancer and its effect on the cellular procedures and signalling pathways involved in carcinogenesis.

Original languageEnglish
Pages (from-to)S155-S159
JournalJournal of the Pakistan Medical Association
Volume73
Issue number2
DOIs
Publication statusPublished - Feb 2023

Keywords

  • Bone Morphogenetic
  • breast cancers
  • Carcinogenesis
  • Colorectal Neoplasms
  • Organogenesis
  • stem cells

Fingerprint

Dive into the research topics of 'Recent Advancements in Gremlin-1: Breast cancer'. Together they form a unique fingerprint.

Cite this